The New Hampshire Bio/Medical Council has announced that it will kick off its Best in Bio series of educational events with a session titled “Clinical Trials- Why Bother?” on Thursday, March 18th at 5:30 p.m. at the Sheraton Portsmouth Harborside.
All biomedical companies know the power of clinical trials. They add value to each enterprise, whether they are for initial approvals, reimbursement or showing outcomes of existing products. Each year, more and more regulations and institutional requirements add to the complexity and difficulty of completing effective trials. The New Hampshire Bio/Med Council has brought together industry experts to discuss this important aspect of the industry and to answer questions. This panel includes: Cynthia L. Owens, M.A., C.C.R.C. Vice President and Co-Founder of Asentral, Inc., Salisbury, MA, John Schwope, President and Founder, Simplified Clinical Data Systems, Milford, NH and Peter N. Madras, M.D., F.A.C.S., Chairman of Asentral, Inc. IRB.
Attend this outstanding program if you are planning to sponsor a clinical trial, are currently sponsoring clinical trials or are interested in this crucial step towards taking a product to market. This will be of interest to regulatory and clinical professionals along with R&D and general management staff. Tickets are $25.00 for members and $35.00 for non-members. The event begins with networking from 5:30-6:00 p.m. followed by the panel. Light refreshments will be served. Registration information can be found at www.nhbiomed.org/bestinbio.